Sacramento, CA — May 15, 2025 — Novogene US today announced the release of its 10x Visium HD 3′ Spatial Transcriptomics Service, further strengthening its spatial omics portfolio.

Following the successful local deployment of 10x Genomics Visium HD on April 27, Novogene now introduces the Visium HD 3′ solution, which adopts a poly(A)-based capture approach, enabling gene expression profiling without reliance on species-specific probes. This allows for broader compatibility across diverse sample types, including non-model organisms.

The service preserves the high spatial resolution of the Visium HD platform while offering a flexible and scalable solution for transcriptome analysis. It supports a wide range of applications, including tumor microenvironment studies, immune profiling, and developmental biology research, particularly in settings where cross-species analysis is required.

With integrated laboratory workflows and advanced bioinformatics support, Novogene delivers an end-to-end spatial transcriptomics solution, further enhanced by Visium HD 3′ to support diverse research applications.

Novogene is also offering a limited-time promotion for both Visium HD and Visium HD 3′ services. For more information, please visit our service page.